Joint

Fujitsu Leverages Deep Learning to Achieve World's Most Accurate Recognition of Complex Actions and Behaviors Based on Skeleton Data

Wednesday, January 13, 2021 - 1:55am

This makes it possible to achieve greater accuracy in recognizing, for instance, when a person performs a task like removing objects from a box.

Key Points: 
  • This makes it possible to achieve greater accuracy in recognizing, for instance, when a person performs a task like removing objects from a box.
  • In recent years, advances in AI technology have made it possible to recognize human behavior from video images using deep learning.
  • Complex movements like unpacking involve hand, elbow, and shoulder joints moving in tandem with the arm bending and stretching.
  • Deep learning technology that can recognize a variety of subtle and complex human movements without relying on large amounts of training data.

HerbSaver: Cannabis Elevated

Wednesday, January 6, 2021 - 6:00pm

Lake Villa, IL, Jan. 06, 2021 (GLOBE NEWSWIRE) -- HerbSaver is revolutionizing one of the worlds fastest-growing industries, cannabis.

Key Points: 
  • Lake Villa, IL, Jan. 06, 2021 (GLOBE NEWSWIRE) -- HerbSaver is revolutionizing one of the worlds fastest-growing industries, cannabis.
  • HerbSaver offers premium grinders and containers for the cannabis, tobacco and culinary industry.
  • We are the owners of the worlds largest and most followed herb grinder brand.
  • We design new products for the cannabis, tobacco and culinary industry.

Osteoarthritis Therapeutics Market worth $11.0 billion by 2025 - Exclusive Report by MarketsandMarkets™

Monday, December 14, 2020 - 2:30pm

"Knee osteoarthritis therapeutics is expected to hold the largest share of the osteoarthritis therapeutics market, by anatomy in 2020."

Key Points: 
  • "Knee osteoarthritis therapeutics is expected to hold the largest share of the osteoarthritis therapeutics market, by anatomy in 2020."
  • Based on anatomy, the market is segmented into knee, hip, hand, and small-joint osteoarthritis therapeutics.
  • Knee osteoarthritis therapeutics is the largest and the fastest-growing segment in this market.
  • The viscosupplementation agents segment accounted for the largest share of the osteoarthritis therapeutics market in 2019.

Osteoarthritis Therapeutics Market worth $11.0 billion by 2025 - Exclusive Report by MarketsandMarkets™

Monday, December 14, 2020 - 2:30pm

"Knee osteoarthritis therapeutics is expected to hold the largest share of the osteoarthritis therapeutics market, by anatomy in 2020."

Key Points: 
  • "Knee osteoarthritis therapeutics is expected to hold the largest share of the osteoarthritis therapeutics market, by anatomy in 2020."
  • Based on anatomy, the market is segmented into knee, hip, hand, and small-joint osteoarthritis therapeutics.
  • Knee osteoarthritis therapeutics is the largest and the fastest-growing segment in this market.
  • The viscosupplementation agents segment accounted for the largest share of the osteoarthritis therapeutics market in 2019.

PetVivo Holdings, Inc. Announces Sponsored Research Agreement with Colorado State University for Osteoarthritis Treatment Study.

Thursday, November 12, 2020 - 1:00pm

Felix Duerr, DVM, associate professor of small animal orthopedics, will serve as Principal Investigator for the research project.

Key Points: 
  • Felix Duerr, DVM, associate professor of small animal orthopedics, will serve as Principal Investigator for the research project.
  • KUSH is a medical device that is administered by intraarticular injection in afflicted joints of animals, such as dogs and horses, for the treatment of osteoarthritis.
  • The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way.
  • The Companys lead product Kush, a veterinarian-administered, intraarticular injection for the treatment of osteoarthritis in dogs and horses, is scheduled for expanded commercial sale later this year.

The Cone+ makes smoking a pre-rolled joint less harmful

Tuesday, November 10, 2020 - 12:01pm

The pre-rolled Cone+ joint, in which consumers can put cannabis, comes standard with a patented CTIP filter.

Key Points: 
  • The pre-rolled Cone+ joint, in which consumers can put cannabis, comes standard with a patented CTIP filter.
  • This cone shaped filter contains high grade activated carbon made from natural coconut shells, which removes harmful and toxic substances from the smoke.
  • The filter does not get everything out, but in any case makes smoking a pre-rolled joint less harmful, says I-nvention.
  • The company has designed the filter cone-shaped, allowing consumers to roll a joint more easily if they want to do that themselves.

The Cone+ makes smoking a pre-rolled joint less harmful

Tuesday, November 10, 2020 - 11:52am

The pre-rolled Cone+ joint, in which consumers can put cannabis, comes standard with a patented CTIP filter.

Key Points: 
  • The pre-rolled Cone+ joint, in which consumers can put cannabis, comes standard with a patented CTIP filter.
  • This cone shaped filter contains high grade activated carbon made from natural coconut shells, which removes harmful and toxic substances from the smoke.
  • The filter does not get everything out, but in any case makes smoking a pre-rolled joint less harmful, says I-nvention.
  • The company has designed the filter cone-shaped, allowing consumers to roll a joint more easily if they want to do that themselves.

Impressio Inc. and MedShape, Inc. Awarded Competitive Grant from the National Science Foundation to Develop Joint Replacement Device

Tuesday, July 28, 2020 - 3:03pm

Approximately 2.5% of people over 50 years old, which is roughly 2-3 million people in the U.S., develop hallux rigidus.

Key Points: 
  • Approximately 2.5% of people over 50 years old, which is roughly 2-3 million people in the U.S., develop hallux rigidus.
  • By exploiting the LCE's inherent dissipative and anisotropic behavior, Impressio and MedShape will collaboratively develop an MTP joint replacement that better replicates the structural and biomechanical function of native cartilage while also reducing wear.
  • The results of this work could also have broader potential use to treat arthritis in other joints in the foot, hand, and knee.
  • About Impressio, Inc.: Impressio Inc. is the first to develop a breakthrough in liquid crystal elastomers (LCEs) technology.

New Book by Dr. Angela Cortal, 'Younger Joints Today' Launches Today (7/27/20)

Monday, July 27, 2020 - 1:33pm

PORTLAND, Ore., July 27, 2020 /PRNewswire/ --Dr. Angela Cortal releases her new book today, Younger Joints Today : Your 7 Step Plan to turn back the hands of time and get your joints healing, moving and feeling their best.

Key Points: 
  • PORTLAND, Ore., July 27, 2020 /PRNewswire/ --Dr. Angela Cortal releases her new book today, Younger Joints Today : Your 7 Step Plan to turn back the hands of time and get your joints healing, moving and feeling their best.
  • Her story begins with a debilitating knee injury that resulted in years of chronic pain, feeling stuck, and out of options.
  • "If deep down you know that there's more to your joint pain than just 'wear and tear,' you're absolutely right.
  • Addressing those missing pieces of the puzzle just might be your key to Younger Joints Today."

Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds

Monday, July 20, 2020 - 12:00pm

Numerous studies published in peer reviewed scientific journals demonstrate that cannabis derived compounds bind to the Gi protein-coupled A3AR, which is over-expressed in pathological cells and tissues.

Key Points: 
  • Numerous studies published in peer reviewed scientific journals demonstrate that cannabis derived compounds bind to the Gi protein-coupled A3AR, which is over-expressed in pathological cells and tissues.
  • As a global leader in discovering and developing drugs which target A3AR, Can-Fite is utilizing its platform technology to develop cannabis derived compounds for the treatment of unmet medical needs.
  • In addition to using its assay in the development of its own cannabis derived compound-based therapeutics, Can-Fite plans to market the assay on a fee for service basis to researchers and other cannabis companies worldwide.
  • According to Adroit Market Research, the medical cannabis market is projected to grow at a CAGR of 29% to $56.7 billion by 2026.